Tetra Bio-Pharma Inc. (TBPMQ)

Market Cap	516.00
Revenue (ttm)	n/a
Net Income (ttm)	-29.84M
Shares Out	515.63M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	71,995
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0000 - 0.0002
Beta	34.30
RSI	40.47
Earnings Date	n/a

About Tetra Bio-Pharma

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and ...

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 33
• Stock Exchange: OTCMKTS
• Ticker Symbol: TBPMQ

Financial Performance

Financial numbers in CAD